Impact of Public Reporting and Outlier Status Identification on Percutaneous Coronary Intervention Case Selection in Massachusetts  by McCabe, James M. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 6 , N O . 6 , 2 0 1 3
ª 2 0 1 3 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 3 . 0 1 . 1 4 0Impact of Public Reporting and
Outlier Status Identiﬁcation on
Percutaneous Coronary Intervention
Case Selection in MassachusettsJames M. McCabe, MD,* Karen E. Joynt, MD, MPH,*y Frederick G. P. Welt, MD, MSC,*
Frederic S. Resnic, MD, MSCz
Boston and Burlington, MassachusettsJACC: CARDIOVASCULAR INTERVENTIONS
CME
This article has been selected as this issue’s CME activity,
available online at http://interventions.onlinejacc.org/ by
selecting the CME tab on the top navigation bar.
Accreditation and Designation Statement
The American College of Cardiology Foundation (ACCF) is
accredited by the Accreditation Council for Continuing
MedicalEducation (ACCME) toprovide continuingmedical
education for physicians. The ACCF designates this Journal-
basedCMEactivity for amaximumof 1AMAPRACategory 1
Credit(s). Physicians should only claim credit commensu-
rate with the extent of their participation in the activity.
Method of Participation and
Receipt of CME Certiﬁcate
To obtain credit for this CME activity, you must:
1. Be an ACC member or JACC: Cardiovascular Interven-
tions subscriber
2. Carefully read the CME-designated article available
online and in this issue of the journal.
3. Answer the post-test questions. At least 2 out of the 3
questions provided must be answered correctly to obtain
CME credit.
4. Complete a brief evaluation.
5. Claim your CME credit and receive your certiﬁcate
electronically by following the instructions given at the
conclusion of the activity.
CME Objective for This Article: To recognize that
public reporting of hospitals’ PCI outcomes may lead to
operator risk aversion and avoidance of PCI in the sickest
patients.
CME Editor Disclosure: JACC: Cardiovascular Inter-
ventions CME Editor Habib Samady, MB, ChB, FACC,
has research grants from the Wallace H. Coulter Founda-
tion, Volcano Corp., St. Jude Medical, Forrest Pharma-
ceuticals Inc., and Pﬁzer Inc.
Author Disclosure: The authors have reported that they
have no relationships relevant to the contents of this paper
to disclose.
Medium of Participation: Print (article only); online
(article and quiz).
CME Term of Approval:
Issue Date: June 2013
Expiration Date: May 31, 2014
From the *Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
yDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts; zDivision of
Cardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts, Tufts Medical School, Boston, Massachusetts. The authors
have reported that they have no relationships relevant to the contents of this paper to disclose. Data previously presented as a Best
Poster ﬁnalist at the Scientiﬁc Sessions of the American College of Cardiology, 2012, Chicago, Illinois.
Manuscript received November 10, 2012; revised manuscript received January 2, 2013, accepted January 18, 2013.
McCabe et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 6 , 2 0 1 3
Impact of PCI Public Reporting in Massachusetts J U N E 2 0 1 3 : 6 2 5 – 3 0
626Impact of Public Reporting and Outlier Status Identiﬁcation on
Percutaneous Coronary Intervention Case Selection
in MassachusettsObjectives This study sought to evaluate the impact of public reporting of hospitals as negative outliers
on percutaneous coronary intervention (PCI) case-mix selection.
Background Public reporting of risk-adjusted in-hospital mortality after PCI is intended to improve
outcomes. However, public labeling of negative outliers based on risk-adjusted mortality rates may
detrimentally affect hospitals’ willingness to care for high-risk patients.
Methods We used generalized estimating equations to examine expected in-hospital mortality rates for
116,227 PCI patients at all nonfederally funded Massachusetts hospitals performing PCI from 2003 to
2010. The main outcome measure was the change in predicted in-hospital mortality rates per hospital
after outlier status identiﬁcation.
Results The prevalence-weighted mean expected mortality for all PCI cases during the study period
was 1.38  0.36% (5.3  1.96% for all shock or ST-segment elevation myocardial infarction patients, 0.58
 0.19% for all not shock, not ST-segment elevation myocardial infarction patients). After public
identiﬁcation as a negative outlier institution, there was an 18% relative reduction (absolute 0.25%
reduction) in predicted mortality among PCI patients at outlier institutions (95% conﬁdence
interval: 0.04 to 0.46%, p ¼ 0.021) compared with nonoutlier institutions. Throughout the study
period, there was an additional 37% relative (0.51% absolute) reduction in the predicted mortality risk
among all PCI patients in Massachusetts attributable to secular changes since the onset of public
reporting (95% conﬁdence interval: 0.20 to 0.83, p ¼ 0.002).
Conclusions The risk proﬁle of PCI patients at outlier institutions was signiﬁcantly lower after public
identiﬁcation compared with nonoutlier institutions, suggesting that risk-aversive behaviors among PCI
operators at outlier institutions may be an unintended consequence of public reporting in
Massachusetts. (J Am Coll Cardiol Intv 2013;6:625–30) ª 2013 by the American College of Cardiology
FoundationSee page 631Public reporting of risk-adjusted in-hospital mortality rates
after percutaneous coronary intervention (PCI) is intended
to build public trust and encourage adoption of best practices
(1). However, there is controversy regarding the ability
of public reporting to improve patient outcomes while
preserving access to potentially lifesaving care (1–5). Public
reporting has been associated with reduced mortality rates
for ST-segment elevation myocardial infarction (STEMI)
and shock patients in both Massachusetts and New York
State (1), but some argue that this may be largely the result
of avoidance of high-risk patients (6).
One important aspect of public reporting that has been
less well studied is the public labeling of institutions as
negative outliers. Negative outlier status is conferred on
institutions whose observed risk-adjusted in-hospital
mortality rate is signiﬁcantly greater than expected based
on risk prediction models. Since the inception of public
reporting in Massachusetts in 2003, 4 institutions have
been identiﬁed as negative outliers. We hypothesized thatPCI operators at institutions previously identiﬁed as
negative outliers may become more intensely risk aversein PCI case selection compared with physicians at non-
outlier centers and therefore more likely to avoid per-
forming PCI in the most severely ill individuals.
Paradoxically, these critically ill patients may stand the
most to gain from reperfusion therapy, albeit with a poor
overall prognosis (7).
Therefore, we set out to answer the following question:
Was identiﬁcation as an outlier for PCI mortality rate in
Massachusetts associated with a change in the risk proﬁle
of patients receiving PCI at that hospital in subsequent
years compared with patients treated at nonoutlier
hospitals?
Abbreviations
and Acronyms
CABG = coronary artery
bypass graft
Mass-DAC = Massachusetts
Data Analysis Center
PCI = percutaneous coronary
intervention
SMIR = standardized
expected mortality incidence
rate
SOS = shock or ST-segment
elevation myocardial
infarction
STEMI = ST-segment
elevation myocardial
infarction
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627Methods
Data source. The Massachusetts Data Analysis Center
(Mass-DAC) collects, adjudicates, and analyzes patient-
speciﬁc risk factors and outcomes for each nonfederal
hospital performing PCI in Massachusetts. Mass-DAC uses
validated risk prediction models to calculate the expected
mortality rates for all patients based on their clinical char-
acteristics and presentation condition. Separate prediction
models are used for shock or STEMI (SOS) PCI patients
and not-shock, not-STEMI (non-SOS) PCI patients (8).
Both expected mortality models were generated yearly to
ensure prediction validity and thus model covariates and the
point estimates of those covariates were subject to change
throughout the study period (Online Tables 1 and 2 list all
model covariates and their respective point estimates per
year). Model covariates include elements collected for
reporting to the National Cardiovascular Data Registry,
whose reporting is mandatory in Massachusetts, as well as
additional exceptionally high-risk elements not collected for
the National Cardiovascular Data Registry but previously
validated for improved model ﬁt in exceptionally high-risk
cases (6). The area under the receiver-operating character-
istic curve for the resultant Mass-DAC models ranged from
0.83 to 0.91 during the study period, suggesting excellent
model discrimination (Online Tables 1 and 2). Averaged
expected mortality rates per PCI-performing hospital are
reported as standardized expected mortality incidence rates
(SMIRs). Because separate prediction models are used for
SOS patients and non-SOS patients, separate SMIRs for
each group are also reported per institution (8). These
SMIRs are published yearly and represent the average ex-
pected in-hospital mortality rates per hospital based on the
characteristics of that institution’s PCI population.
Endpoints and deﬁnitions. We collected publicly reported
SMIRs for both SOS and non-SOS patients at all
PCI-capable, nonfederal Massachusetts hospitals from
2003 through 2010. Prevalence-weighted mean expected
mortality rates were calculated per year by weighting each
hospital’s expected mortality rates for SOS and non-SOS
patients by those hospitals’ respective number of SOS and
non-SOS cases. The pre-speciﬁed primary outcome of this
study was the change in average expected mortality rates for
all patients undergoing PCI at institutions previously labeled
as negative outliers compared with the changes in expected
mortality rates from all nonoutlier hospitals during that time
frame. Comparisons with contemporary nonoutlier hospitals
account for yearly changes in the Mass-DAC expected
mortality models and the possibility that public reporting
and, more speciﬁcally, the identiﬁcation of outlier hospitals,
might lead to “risk avoidance creep” among all hospitals
and not just outliers. The primary predictor was outlier
status as reported by Mass-DAC. During the study period,
4 hospitals were reported to be negative outliers: 1 in 2005,2 in 2007, and 1 in 2009. For the purposes of this analysis,
institutions were not considered outliers until the year of
their public identiﬁcation but remained outliers for all
subsequent years after their identiﬁcation. To determine
whether patients at outlier institutions were being routed
toward coronary artery bypass graft (CABG) surgery instead
of PCI after outlier status identiﬁcation, we also collected
publicly available SMIRs created by Mass-DAC for per-
hospital projected 30-day mortality rates after isolated
CABG to examine concomitant changes in the illness
severity of this population.
Statistical analysis. Simple comparisons of normally and non-
normally distributed data were performed using the Student t
test and Wilcoxon rank sum test, respectively. We used
generalized estimating equations for multivariate regression
analyses comparing outliers with nonoutliers while accounting
for nested and repeated measures among speciﬁc hospitals.
Thesemultivariablemodelswere adjusted for secular trends by
incorporating the years analyzed.
Analyses were performed with
Stata version 11 (StataCorp, Col-
lege Station, Texas). Institutional
review board approval was waived
because all analyses were per-
formed using aggregate publicly
reported data.
Results
Baseline characteristics. Twenty-
four Massachusetts hospitals
performed 116,227 PCI proce-
dures between 2003 and 2010.
The prevalence-weighted mean
expected mortality rate for all
PCI cases during the study pe-
riod was 1.38  0.36% (5.3  1.96% for all SOS patients,
0.58  0.19% for all non-SOS patients).
Outlier hospitals were larger on average than nonoutlier
hospitals (p ¼ 0.03) and signiﬁcantly more PCI procedures
were performed per year (192  80 vs. 112  76 SOS, and
1,163  200 vs. 780  408 non-SOS cases, respectively;
both p < 0.01) (Table 1).
Changes in expected mortality rate of PCI patients. On
average, after hospitals were labeled as negative outliers,
the expected mortality rate of their PCI patients was
signiﬁcantly lower than at nonoutlier institutions (1.08 
0.23% vs. 1.58  0.29%, p < 0.01), suggesting the average
PCI patient at outlier institutions was less severely ill.
Speciﬁcally, outlier institutions had signiﬁcantly lower rates
of expected mortality among non-SOS patients compared
with non-SOS patients at nonoutlier institutions (0.47 
0.18% vs. 0.60  0.18%, p < 0.01), whereas the illness
severity of SOS patients, as reﬂected in their expected
Table 1. Hospital-Based Differences Between Outlier and Nonoutlier Institutions
Outlier
(n ¼ 4)
Nonoutlier
(n ¼ 20) p Value
Mean no. of inpatient beds 590  341 334  173 0.03
Average expected mortality, all PCIs 1.08  0.23* 1.58  0.29 <0.01
Average expected mortality, shock, or STEMI 5.22  1.28* 5.31  2.02 0.87
Average expected mortality, not shock and not STEMI 0.47  0.18* 0.60  0.18 <0.01
Average shock or STEMI case volume/yr 192  80 112  76 <0.01
Average not shock, not STEMI case volume/yr 1,163  200 780  408 <0.01
Cardiothoracic surgery backup present (%) 4 (100) 10 (50) <0.01
Values are mean  SD or n (%). *Mean since outlier status identiﬁcation.
PCIs ¼ percutaneous coronary interventions; STEMI ¼ ST-segment elevation myocardial infarction.
Figure 1. Expected Mortality Rate After Percutaneous Coronary
Intervention at Outlier Versus Nonoutlier Institutions
Mean prevalence-weighted in-hospital expected mortality rate per year for
outlier and nonoutlier hospitals. Error bars represent SDs. PCI ¼ percutaneous
coronary intervention.
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628mortality rates, did not appear to differ signiﬁcantly
between the 2 groups (5.22  1.28% vs. 5.31  2.02%,
p ¼ 0.87).
When expected mortality rates at outlier institutions
(post-identiﬁcation) were compared with themselves pre-
identiﬁcation, even greater differences were seen in both
SOS and non-SOS expected mortality rates: 7.49 
3.47% (pre-) vs. 5.22  1.78% (post-), p ¼ 0.03; and
0.71  0.18% (pre-) vs. 0.47  0.18% (post-), p <0.01,
respectively.
After adjusting for temporal trends across the state,
there was a signiﬁcant 18% relative reduction (or an abso-
lute 0.25% reduction) in predicted mortality among PCI
patients at hospitals after public identiﬁcation as an outlier
compared with nonoutliers (95% conﬁdence interval [CI]:
0.46 to 0.04%, p ¼ 0.021) (Fig. 1). Furthermore, there
was a 37% relative reduction (0.51% absolute decrease, or
0.06% per year decrease) in the predicted mortality rates of
all PCI patients in Massachusetts attributable to secular
changes since the onset of public reporting (95% CI: 0.83
to 0.20, p ¼ 0.002).
Changes in observed mortality rate of PCI patients. Of note,
the changes in expected mortality rates calculated from
patient risk proﬁles paralleled the actual observed in-hospital
mortality rates after PCI over the study period. The overall
observed statewide mortality rates signiﬁcantly decreased
from 1.70% in 2003 to 1.34% in 2010 (p ¼ 0.02 for trend)
(Fig. 2).
CABG surgery among outlier hospitals. All centers ultimately
identiﬁed as outlier institutions also offered CABG surgery
throughout the study period. Since the inception of public
reporting of PCI outcomes in Massachusetts, the average
expected 30-day mortality rates after CABG surgery at these
4 institutions has decreased from 2.50  0.39% to 1.23 
0.03% (p ¼ 0.01 for trend) (Fig. 3), suggesting that the
decrement in average illness severity of the PCI population
at those outlier institutions is not likely due to redirecting
their most severely ill patients toward an operative reperfu-
sion strategy.Discussion
Using expected mortality rates for each hospital as
a surrogate for the case mix of its PCI population, we
found that the aggregate illness severity of PCI patients at
institutions previously labeled as an outlier was signiﬁcantly
lower than contemporaneous measures at other Massa-
chusetts institutions that had not previously been labeled as
a negative outlier. This suggests that risk-aversive behav-
iors among PCI operators at outlier institutions may be an
unintended consequence of public reporting in Massa-
chusetts. Concomitantly, there was a signiﬁcant temporal
trend toward a lower average illness severity for PCI
patients across all hospitals in the state since the inception
Figure 2. Observed Percutaneous Coronary Intervention Mortality
Rate per Year in Massachusetts
Statewide, per-year unadjusted observed in-hospital mortality rates after
percutaneous coronary intervention for all patients at nonfederal hospitals
since the inception of the public reporting process in Massachusetts.
Observed mortality, best ﬁt, and 95% conﬁdence interval (CI) for ﬁt.
Figure 3. Expected Mortality Rate After CABG Surgery
at Outlier Institutions
Mean expected mortality after coronary artery bypass graft (CABG) surgery
at the 4 institutions labeled as outliers for their percutaneous coronary
intervention outcomes since the inception of Massachusetts public reporting.
Error bars represent SDs.
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629of public reporting of PCI outcomes; whether this was
a result of public reporting or simply reﬂective of larger
national trends is unknown, although previous work
suggests that this may be a consequence of the public
reporting process (9).
The mechanism for the decrease in expected in-hospital
mortality rate among PCI patients at outlier institutions is
unclear. An improvement in PCI performance or quality
may improve observed mortality rates after PCI, but should
not affect the expected mortality rates that were used for this
analysis because they are calculated based on patients’
presentation characteristics. It is therefore likely that public
reporting leads some PCI operators to avoid those patients
whom they perceive to be at the highest risk of adverse
outcomes and hence most likely to negatively affect their
publicly reported performance. In fact, we suspect that the
mechanism for the decreased average illness severity among
PCI case mix at outlier hospitals is to avoid PCI altogether
in the most severely ill SOS patients.
Although we did not observe a difference in the ex-
pected risk of SOS patients who underwent PCI after
outlier status identiﬁcation, our analysis cannot account for
patients who might qualify for PCI but were no longer
offered this therapy. Avoiding interventions in the most
severely ill SOS patients who might otherwise have indi-
cations for PCI would decrease that institution’s aggregate
expected mortality rate by relatively increasing the
proportion of lower risk, nonshock, non-STEMI patients
among the total PCI population. This hypothesis is
consistent with the 30% reduction in STEMI patients with
shock who underwent PCI after implementation of publicreporting of PCI outcomes in New York State between
1997 and 2003 (1) and is in accord with a recent analysis
suggesting that, compared with states without public
reporting, states with PCI outcome reporting (including
Massachusetts) demonstrate the most signiﬁcant decre-
ment in PCI application among patients with STEMI or
shock (9). Nevertheless, an analysis of all PCI-eligible
patients in Massachusetts is required to further evaluate
our ﬁndings regarding the effects of outlier status on PCI
case mix.
Interestingly, we also found that the average illness
severity of the non-SOS patients, a generally lower risk
group, signiﬁcantly decreased after outlier status identiﬁca-
tion. It is unclear why statistically measurable changes not
seen among the SOS cohort would be seen in this group
after outlier status identiﬁcation; it may be that the decision
to provide PCI is generally more discretionary in a lower risk
cohort than in the SOS group, or it may be related statis-
tically to the far greater volume of nonshock, non-STEMI
patients undergoing PCI.
Study limitations. First, our analyses were limited to publicly
available per-hospital data, and thus speciﬁc patient-level
information was not incorporated. Second, we were unable
to account directly for differences in risk factor documen-
tation. Previous experience suggest that more rigorous risk
proﬁle documentation after public reporting, sometimes
referred to as up-coding, may be common (10). Up-coding
has the potential to falsely inﬂate predicted patient mortality
rate and therefore dilute any change in quantiﬁable risk
aversion after outlier status identiﬁcation. Up-coding would
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630have biased this analysis against ﬁnding an even greater
effect. Additionally, as noted previously, our data cannot
account for the patients who might have qualiﬁed for PCI
during the study period but who did not receive it as a result
of risk-aversive behavior because those subjects are not
recorded in this PCI-based dataset. Finally, we cannot
account for the exact timing of institutional notiﬁcation
regarding their public identiﬁcation as an outlier. We chose
to stratify institutions as outliers for the purposes of this
analysis based on the year for which they were cited, but it is
possible that these institutions may not have been alerted to
the change in their public reporting status until many
months later. Stratifying institutions as outliers for the
purposes of this analysis before they were alerted to their
status changes would also be expected to bias our results
toward the null.Conclusions
Taken as a whole, these data suggest that the public
reporting of in-hospital mortality after PCI and the
practice of public identiﬁcation of hospitals as negative
outliers may increase risk avoidance in a manner incon-
sistent with best practices. Arguably, an aversion to per-
forming PCI in the sickest patients at poorly performing
hospitals is, in fact, the intended consequence of public
reporting of PCI outcomes. However, the hospitals iden-
tiﬁed as negative outliers in Massachusetts were larger
centers with greater average procedure volumes, features
classically associated with superior technical performance
(11–13). Additionally, we did not observe a reciprocal
increase in the aggregate expected mortality of those
institutions’ CABG patients or in PCI patients at non-
outlier institutions as one might expect to ﬁnd if the most
severely ill patients were being redirected from “poorer
performing” outlier hospitals’ catheterization laboratories
to their operating rooms for CABG or to “better per-
forming” nonoutlier hospitals for PCI.
Interestingly, in the era of public reporting, the severity of
illness of all PCI patients has diminished despite a contem-
poraneous movement toward PCI “appropriateness,” which
generally encourages reserving PCI for higher acuity and
more severely symptomatic patients (14). During this period,
both the expected and observed in-hospital mortality rates
after PCI declined in Massachusetts, although the relative
contributions of quality improvement and risk aversion to
this trend remain unclear. Further studies on publicly
labeling institutions as negative outliers based on in-hospitalPCI mortality rate are necessary to assess its impact on
operator behavior and case-mix selection.
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